Search

everythinglearnresearchcommunity

for

Search:↓

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Better hair loss models needed for research.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

People with male pattern baldness are more likely to have metabolic syndrome.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Finasteride may improve prostate cancer treatment outcomes.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

AI-assisted surgical robots improve surgery precision and safety.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.